Living Donor Liver Transplantation (LDLT) is a valuable solution to the shortage of donor organs for patients with end-stage liver disease. However, the eligibility of obese donors for LDLT remains a subject of debate. This literature review explores global practices and perceptions of LDLT, identifies donor eligibility criteria, and discusses special considerations and ethical caveats. The review highlights the need for standardized guidelines for donor selection, considering the global distribution of Body mass index and variations in population-specific criteria. It also emphasizes the importance of non-invasive testing and pre-operative optimization of liver steatosis for select obese donors. Furthermore, the review examines the outcome...
Obese patients are at higher risk for morbidity and mortality after liver transplantation (LT) than ...
Background Current American and European guidelines consider a pre-transplant BMI â\u89¥40 kg/m2 as ...
Liver transplantation has become the mainstay for the treatment of end-stage liver disease, hepatoce...
Living donor liver transplantation (LDLT) is an accepted option for end-stage liver disease, particu...
Background. Living liver donor obesity has been considered a relative contraindication to living don...
Background. There are limited data on liver transplant (LT) outcomes with grafts from super obese do...
Living-donor liver transplant allows for expedited transplant, with outcomes shown to be superior co...
Despite the rapidly increasing prevalence of obesity in the transplant population, the optimal manag...
OBJECTIVES: The effect of morbid obesity on liver transplant outcomes has yielded mixed results. The...
There is a paucity of literature examining recipient-donor obesity matching on liver transplantation...
Background. Living donor liver transplantation offers an attractive option to reduce the waitlist mo...
Abstract Background The significance of pre‐operative body composition has recently attracted much a...
Background: The significance of pre‐operative body composition has recently attracted much attention...
In the last 30 years, operative, technical and medical advances have made liver transplantation (LT)...
Short- and long-term results of liver transplantation in morbidly obese patients may be impaired com...
Obese patients are at higher risk for morbidity and mortality after liver transplantation (LT) than ...
Background Current American and European guidelines consider a pre-transplant BMI â\u89¥40 kg/m2 as ...
Liver transplantation has become the mainstay for the treatment of end-stage liver disease, hepatoce...
Living donor liver transplantation (LDLT) is an accepted option for end-stage liver disease, particu...
Background. Living liver donor obesity has been considered a relative contraindication to living don...
Background. There are limited data on liver transplant (LT) outcomes with grafts from super obese do...
Living-donor liver transplant allows for expedited transplant, with outcomes shown to be superior co...
Despite the rapidly increasing prevalence of obesity in the transplant population, the optimal manag...
OBJECTIVES: The effect of morbid obesity on liver transplant outcomes has yielded mixed results. The...
There is a paucity of literature examining recipient-donor obesity matching on liver transplantation...
Background. Living donor liver transplantation offers an attractive option to reduce the waitlist mo...
Abstract Background The significance of pre‐operative body composition has recently attracted much a...
Background: The significance of pre‐operative body composition has recently attracted much attention...
In the last 30 years, operative, technical and medical advances have made liver transplantation (LT)...
Short- and long-term results of liver transplantation in morbidly obese patients may be impaired com...
Obese patients are at higher risk for morbidity and mortality after liver transplantation (LT) than ...
Background Current American and European guidelines consider a pre-transplant BMI â\u89¥40 kg/m2 as ...
Liver transplantation has become the mainstay for the treatment of end-stage liver disease, hepatoce...